Title : KCNJ11 gene E23K variant and therapeutic response to sulfonylureas.

Pub. Date : 2012 Apr

PMID : 22385882






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The relationship of treatment response with KCNJ11 genotype was also significant in the biggest subgroup of patients treated with gliclazide (n=55). Gliclazide potassium inwardly rectifying channel subfamily J member 11 Homo sapiens
2 CONCLUSIONS: Carriers of the KCNJ11 K-allele have better therapeutic response to gliclazide. Gliclazide potassium inwardly rectifying channel subfamily J member 11 Homo sapiens